85 related articles for article (PubMed ID: 3754999)
1. [Treatment of disorders of lipid metabolism with the new lipid regulator X50].
Reuter W; Herrmann W; Sauer I; Janowski K; Dorn H; Steinicke A
Z Gesamte Inn Med; 1986 Mar; 41(5):124-6. PubMed ID: 3754999
[TBL] [Abstract][Full Text] [Related]
2. [Behavior of the biological aging index and serum lipids in treatment with X50].
Reuter W; Sauer I; Herrmann W
Z Alternsforsch; 1986; 41(2):91-4. PubMed ID: 3754998
[TBL] [Abstract][Full Text] [Related]
3. [Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia].
Ivanova TN; Poliakova ED; Olfer'ev AM; Perova NV
Biull Eksp Biol Med; 1998 May; 125(5):569-73. PubMed ID: 9644562
[No Abstract] [Full Text] [Related]
4. [Drug therapy of dyslipidemias].
Fonda M; Cattin L; Guarnieri G
Recenti Prog Med; 2000; 91(7-8):375-8. PubMed ID: 10932924
[No Abstract] [Full Text] [Related]
5. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
[TBL] [Abstract][Full Text] [Related]
6. Relative effectiveness of niacin and lovastatin for treatment of dyslipidemias in a health maintenance organization.
O'Connor PJ; Rush WA; Trence DL
J Fam Pract; 1997 May; 44(5):462-7. PubMed ID: 9152263
[TBL] [Abstract][Full Text] [Related]
7. [Effect of long-term cardiac training on lipids concentration in patients with chronic heart ischemic disease treated with simvastatin].
Kałka D; Sobieszczańska M; Kopka L; Marciniak W; Zawadzka-Bartczak E; Bak A; Popielewicz-Kautz A; Korzeniowska J; Janczak J; Adamus J
Pol Merkur Lekarski; 2007 Feb; 22(128):101-6. PubMed ID: 17598652
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial.
McCrindle BW; Ose L; Marais AD
J Pediatr; 2003 Jul; 143(1):74-80. PubMed ID: 12915827
[TBL] [Abstract][Full Text] [Related]
9. [Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2].
Wolffenbuttel BH; Huijberts MS
Ned Tijdschr Geneeskd; 2001 Apr; 145(16):761-5. PubMed ID: 11346911
[TBL] [Abstract][Full Text] [Related]
10. Artichoke juice improves endothelial function in hyperlipemia.
Lupattelli G; Marchesi S; Lombardini R; Roscini AR; Trinca F; Gemelli F; Vaudo G; Mannarino E
Life Sci; 2004 Dec; 76(7):775-82. PubMed ID: 15581909
[TBL] [Abstract][Full Text] [Related]
11. Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed?
Sarawate CA; Cziraky MJ; Stanek EJ; Willey VJ; Corbelli JC; Charland SL
Clin Ther; 2007 Jan; 29(1):196-209. PubMed ID: 17379061
[TBL] [Abstract][Full Text] [Related]
12. Rationale for and outline of the recommendations of the Working Group on Hypercholesterolemia and Other Dyslipidemias: interim report. Dyslipidemia Working Group of Health Canada.
Frohlich J; Fodor G; McPherson R; Genest J; Langner N
Can J Cardiol; 1998 Apr; 14 Suppl A():17A-21A. PubMed ID: 9594929
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of etofibrate and gemfibrozil in combined hyperlipidaemia.
Wolf HR
Drugs Exp Clin Res; 1994; 20(3):109-13. PubMed ID: 7956717
[TBL] [Abstract][Full Text] [Related]
14. The effect of pirozadil on plasma lipids and lipoproteins in 1185 hyperlipidaemic subjects. Multicentre study in general practice in Spain.
Tapounet R; Marti Ragué I
Drugs Exp Clin Res; 1987; 13(7):447-50. PubMed ID: 3652931
[TBL] [Abstract][Full Text] [Related]
15. [Acipimox (Olbetam) as a secondary hypolipemic agent in combined hypertriglyceridemia and hyperlipidemia].
Yeshurun D; Hamood H; Morad N; Naschitz J
Harefuah; 2000 Apr; 138(8):650-3, 710. PubMed ID: 10883206
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with changes in serum total cholesterol levels over 7 years in middle-aged New Zealand men and women: a prospective study.
Metcalf PA; Scragg RK; Swinburn BA; Shaw LM
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):298-305. PubMed ID: 11887426
[TBL] [Abstract][Full Text] [Related]
17. Management of hypercholesterolaemia in the patient with diabetes.
Packard C; Olsson AG
Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of 12-week treatment with fenofibrate 300 mg in Thai dyslipidemic patients.
Koanantakul B; Jeamanukulkit N; Piamsomboon C; Chawantanpipat C; Khanacharoen I
J Med Assoc Thai; 2004 Nov; 87(11):1281-5. PubMed ID: 15825700
[TBL] [Abstract][Full Text] [Related]
19. Aggressive medical therapy for the prevention and treatment of coronary artery disease.
Malloy MJ; Kane JP
Dis Mon; 1998 Jan; 44(1):1-40. PubMed ID: 9457050
[No Abstract] [Full Text] [Related]
20. Nicotinic acid in the treatment of hyperlipidaemia.
Drexel H
Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():5-6. PubMed ID: 18001312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]